The Panomles Approach in Neurodegenerative Disorders

被引:3
|
作者
Szatmari, Balazs [1 ]
Balicza, Peter [2 ]
Nemeth, Gyorgy [1 ]
Molnar, Maria Judit [2 ]
机构
[1] Gedeon Richter Plc, Med Div, Budapest, Hungary
[2] Semmelweis Univ, Inst Genom Med & Rare Dis Orders, Budapest, Hungary
关键词
Omics; classification; neurodegenerative disorders; multidisciplinary approach; genetics; imaging; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TREM2; VARIANTS; PET; PATHOLOGY; NEUROINFLAMMATION; SAFETY;
D O I
10.2174/0929867324666170705120038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The molecular genetic technologies revolutionized the diagnostics of many disorders. Thanks to the new molecular techniques and the rapid improvement of the information technologies the number of mendelien inherited disorders has increased rapidly in the last five years. The omics era brought radical changes in the understanding of complex disorders and the underlying pathomechanisms. However, in most complex disorders the genome wide association studies could not clarify the genetic background even for disorders where a very strong heritability had been observed. Objective: In this paper the changing concept of the neurodegenerative disorders is discussed. The traditional classification of these disorders was purely based on clinical symptoms and morphological signs in the last century. Identifying the signature lesions of various neurodegenerative disorders may reveal a common pathological pathway in these disorders, New neuroimaging methods provided additional tools to assess pathological pathways in vivo already in the early stages of the diseases, Visualizing in vivo amyloid deposits and neuroinflammation improved our understanding of their role in various neurodegenerative disorders. Genetics may be the most precise way to identify the background of these disorders, However, there is only limited number of cases where true association can he proved between the disorder and the genetic mutations. Most of the neurodegenerative disorders seem to be multifactorial and cannot be traced back to one single cause. Conclusion: In conclusion, shifting from a classification based on symptomatology only to a modern multidisciplinary approach, based on the constantly evolving panomics findings, would improve our understanding of neurodegenerative diseases and could be the basis of novel therapeutic research.
引用
收藏
页码:1712 / 1720
页数:9
相关论文
共 50 条
  • [41] Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
    Lin, Chin-Hsien
    Chiu, Shu-, I
    Chen, Ta-Fu
    Jang, Jyh-Shing Roger
    Chiu, Ming-Jang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 15
  • [42] Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study
    Liu, Wei-Shi
    Zhang, Ya-Ru
    Ge, Yi-Jun
    Wang, Hui-Fu
    Cheng, Wei
    Yu, Jin-Tai
    MOLECULAR NEUROBIOLOGY, 2024, 61 (03) : 1593 - 1604
  • [43] DNA Methylation in Neurodegenerative Disorders
    Zihui Xu
    Xuekun Li
    Current Geriatrics Reports, 2012, 1 (4) : 199 - 205
  • [44] miRNAs as biomarkers of neurodegenerative disorders
    Viswambharan, Vijitha
    Thanseem, Ismail
    Vasu, Mahesh M.
    Poovathinal, Suresh A.
    Anitha, Ayyappan
    BIOMARKERS IN MEDICINE, 2017, 11 (02) : 151 - 167
  • [45] Weight loss in neurodegenerative disorders
    N. A. Aziz
    M. A. van der Marck
    H. Pijl
    M. G. M. Olde Rikkert
    B. R. Bloem
    R. A. C. Roos
    Journal of Neurology, 2008, 255 : 1872 - 1880
  • [46] Peptide Therapeutics in Neurodegenerative Disorders
    Tiwari, Shashi Kant
    Chaturvedi, Rajnish K.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (23) : 2610 - 2631
  • [47] Neurodegenerative disorders:: the role of peroxynitrite
    Torreilles, F
    Salman-Tabcheh, S
    Guérin, MC
    Torreilles, J
    BRAIN RESEARCH REVIEWS, 1999, 30 (02) : 153 - 163
  • [48] Open Science Meets Stem Cells: A New Drug Discovery Approach for Neurodegenerative Disorders
    Han, Chanshuai
    Chaineau, Mathilde
    Chen, Carol X. -Q.
    Beitel, Lenore K.
    Durcan, Thomas M.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [49] Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
    Roussos, Antonis
    Kitopoulou, Katerina
    Borbolis, Fivos
    Palikaras, Konstantinos
    BIOMOLECULES, 2023, 13 (03)
  • [50] TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders
    Berdynski, Mariusz
    Ludwiczak, Jan
    Barczak, Anna
    Barcikowska-Kotowicz, Maria
    Kuzma-Kozakiewicz, Magdalena
    Dunin-Horkawicz, Stanislaw
    Zekanowski, Cezary
    Borzemska, Beata
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (04) : 1211 - 1219